FDA 483 - Neogen Corporation - March 16, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Neogen Corporation, an animal drug manufacturer in Lexington, KY, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate laboratory record-keeping and data integrity controls, improper storage conditions for drug products, failure to follow stability testing programs, and insufficient control over label and labeling material access and destruction of obsolete materials. These issues indicate significant concerns regarding quality control and adherence to good manufacturing practices.
ID · 29796c36-3e69-4d39-87b0-293fe9baa378